AFFYIMMUNE THERAPEUTICS
AffyImmune Therapeutics is a biopharmaceutical company specializing in affinity tuned Chimeric Antigen Receptor (“CAR”) T cell therapy in solid tumors. The Company’s proprietary technology may significantly improve the existing CAR-T cell therapy by extending the target of CAR-T therapies to solid tumors using a novel molecule and tuning down the affinity from picomolar to micromolar level to lower the on-target off-tumor toxicity.
AFFYIMMUNE THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Life Science
Founded:
2016-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.affyimmune.com
Total Employee:
1+
Status:
Active
Contact:
(617) 699-1965
Total Funding:
28.9 M USD
Similar Organizations
Civitas Therapeutics
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Resolution Therapeutics
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
ORI Capital
ORI Capital investment in Series A - AffyImmune Therapeutics
Key Employee Changes
Official Site Inspections
http://www.affyimmune.com
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AffyImmune Therapeutics"
About - AffyImmune Therapeutics, Inc.
Prior to joining AffyImmune, he was the Chief Medical Officer of FibroGen and previously the …See details»
AffyImmune Therapeutics, Inc.
AffyImmune is focused on cancers where ICAM-1 overexpression plays a key role. Learn More. Clinical Indications. Although most thyroid cancers are curable, prognosis is very poor for anaplastic and advanced differentiated thyroid …See details»
AffyImmune Therapeutics - Crunchbase Company …
AffyImmune Therapeutics is a biopharmaceutical company specializing in affinity tuned Chimeric Antigen Receptor (“CAR”) T cell therapy in solid tumors. The …See details»
AffyImmune Therapeutics - LinkedIn
AffyImmune Therapeutics | 3,107 followers on LinkedIn. Biotechnology startup developing …See details»
Affyimmune Therapeutics, Inc. Company Profile | Natick, MA ...
Find company research, competitor information, contact details & financial data for Affyimmune …See details»
Pipeline - AffyImmune Therapeutics, Inc.
AffyImmune Therapeutics Inc. 22 Strathmore Road, Natick, MA 01760. ph: (508) 654-3600See details»
Affyimmune Company Profile - Office Locations, Competitors
AffyImmune Therapeutics is a biotechnology company that focuses on cell-based …See details»
Affyimmune Therapeutics Company Profile -Sales, Contacts, …
Affyimmune Therapeutics is located in Natick, Massachusetts. This organization primarily …See details»
AffyImmune Therapeutics - PitchBook
AffyImmune Therapeutics was founded in 2016. Where is AffyImmune Therapeutics …See details»
AffyImmune Therapeutics, Inc. | ClinEco
Contact AffyImmune Therapeutics, Inc. The Contact Us Form is the main in-app …See details»
AffyImmune Therapeutics - VentureRadar
AffyImmune’s “Tune & Track” platform finely tunes the affinity of CAR T cells to reduce toxicity …See details»
AffyImmune Therapeutics - Funding, Financials, Valuation
How much funding has this organization raised over time? Show . Announced Date . …See details»
AffyImmune Therapeutics - Overview, News & Similar companies
Nov 17, 2023 AffyImmune Therapeutics Announces Hiring of Dr. Sonal Gupta as Senior Vice …See details»
AffyImmune Therapeutics - Contacts, Employees, Board Members, …
Organization. AffyImmune Therapeutics . Connect to CRM . Save . Summary. Financials. …See details»
Affyimmune Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Explore Affyimmune Therapeutics, Inc. with its drug pipeline, therapeutic area, technology …See details»
AffyImmune Appoints Dr. Daniel Janse as Chief Executive Officer
Jul 15, 2024 NATICK, Mass.--(BUSINESS WIRE)--AffyImmune, a clinical-stage biotechnology …See details»
AffyImmune Announces Plenary Oral Presentation on ICAM-1 …
3 days ago AffyImmune is a clinical-stage biopharmaceutical company committed to …See details»
AffyImmune hires former venture capital director as new leader, …
Jul 15, 2024 AffyImmune is working to develop CAR T cell therapies, which utilizes patients’ …See details»
AffyImmune Appoints Dr. Daniel Janse as Chief Executive Officer
Jul 15, 2024 AffyImmune is a clinical-stage biopharmaceutical company committed to …See details»
AffyImmune Appoints Deyaa Adib, MD as Chief Medical Officer
NATICK, Mass., Nov. 25, 2024 /PRNewswire/ -- AffyImmune Therapeutics, a clinical-stage …See details»